91精品国产综合久久香蕉的用户体验_震车做爰的视频|HD中文字幕在线播放,久久精品8,天天躁日日躁狠狠躁免费麻豆 ,性一交一性一交肉体

  • 新聞與活動

    學術成果

Scaffold Hopping Transformations Using Auxiliary Restraints for Calculating Accurate Relative Binding Free Energies

J. Chem. Theory Comput. 2021, 17, 6, 3710–3726

In silico screening of drug–target interactions is a key part of the drug discovery process. Changes in the drug scaffold via contraction or expansion of rings, the breaking of rings, and the introduction of cyclic structures from acyclic structures are commonly applied by medicinal chemists to improve binding affinity and enhance favorable properties of candidate compounds. These processes, commonly referred to as scaffold hopping, are challenging to model computationally. Although relative binding free energy (RBFE) calculations have shown success in predicting binding affinity changes caused by perturbing R-groups attached to a common scaffold, applications of RBFE calculations to modeling scaffold hopping are relatively limited. Scaffold hopping inevitably involves breaking and forming bond interactions of quadratic functional forms, which is highly challenging. A novel method for handling ring opening/closure/contraction/expansion and linker contraction/expansion is presented here. To the best of our knowledge, RBFE calculations on linker contraction/expansion have not been previously reported. The method uses auxiliary restraints to hold the atoms at the ends of a bond in place during the breaking and forming of the bonds. The broad applicability of the method was demonstrated by examining perturbations involving small-molecule macrocycles and mutations of proline in proteins. High accuracy was obtained using the method for most of the perturbations studied. The rigor of the method was isolated from the force field by validating the method using relative and absolute hydration free energy calculations compared to standard simulation results. Unlike other methods that rely on λ-dependent functional forms for bond interactions, the method presented here can be employed using modern molecular dynamics software without modification of codes or force field functions.

想繼續了解更多?

聯系我們

我們期待您的留言

讓我們知道如何為您提供幫助,我們團隊將24小時內與您聯系!

姓名
電話
郵箱
國家/地區
北京市
天津市
上海市
重慶市
河北省
山西省
遼寧省
吉林省
黑龍江省
江蘇省
浙江省
安徽省
福建省
江西省
山東省
河南省
湖北省
湖南省
廣東省
海南省
四川省
貴州省
云南省
陜西省
甘肅省
青海省
臺灣省
內蒙古自治區
廣西壯族自治區
西藏自治區
寧夏回族自治區
新疆維吾爾自治區
香港特別行政區
澳門特別行政區
從事行業
小分子藥物研發
抗體藥物研發
CRO/CDMO
投融資機構
高校/研究院所/醫院
園區
生物醫藥產業
感興趣的業務
小分子藥物發現
抗體藥物發現
藥物固體形態研發
化學合成服務(含自動化合成)
實驗室自動化解決方案
所在公司
是否需要業務人員跟進?
暫不需要
驗證碼

我已閱讀并同意 晶泰科技隱私政策法律聲明